Recognizing the community’s concern about the USPSTF recommendation regarding screening for ovarian cancer in September 2012, OCRF responded by writing a New York Times Letter to the Editor to reinforce the fact that research is the key and expand our message to a much wider audience. It was published on September 21, 2012.
Related Topics
New AI Accelerator Grant Captures Health and Science Media Attention
OCRA is excited to see the work fueled by our new AI Accelerator Grant resonating with a broad array of audiences. Since the Global Ovarian Cancer Research Consortium announced the inaugural AI Accelerator Grant on February 19, coverage has appeared across health, science, and business media outlets. The $1 million global research award—with an additional … Continued
The Overview: February 2026
The Global Ovarian Cancer Research Consortium and its inaugural AI Accelerator Grant, AI to Predict Exceptional and Poor Survival from Real-World Biomarkers for Clinical Application, have been making waves across health, science, and business media, reflecting widespread interest in what this work could mean for patients. The $1 million global research grant, plus an additional … Continued
Ovarian Cancer Research Alliance Honors Researchers with 2025 Rosalind Franklin and Schreiber Prizes
Recognizing Advances in Ovarian Cancer Research and Immunotherapy Ovarian Cancer Research Alliance (OCRA) announced today the winners of two prizes recognizing exceptional accomplishments in ovarian cancer research. David Huntsman, MD, FRCPC, FCCMG, was awarded the 2025 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research for his findings that have profoundly impacted the treatment of … Continued